Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2002
10/15/2002US6465634 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
10/15/2002US6465633 Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
10/15/2002US6465621 Polypeptides and polynucleotides of the gtp-binding protein family
10/15/2002US6465611 Compounds for immunotherapy of prostate cancer and methods for their use
10/15/2002US6465438 Nucleic acid vaccination for parvoviral infections
10/15/2002US6465422 Method for inhibiting tumor invasion or spreading in a subject
10/15/2002US6465172 HIV immunogenic complexes comprising GP120 covalently bound to CD4 or concanavalin A
10/15/2002US6464998 Composition for the in vivo production of therapeutic products
10/15/2002US6464985 Ospc dra fragment fusion peptide isolated from borrelia burgdorferi
10/15/2002US6464984 Avian polynucleotide vaccine formula
10/15/2002US6464982 Herbal immune system stimulant
10/15/2002US6464980 MAGE-1 c-terminal immunogenic peptides
10/15/2002US6464979 Chlamydial vaccines and methods of preparation thereof
10/15/2002US6464978 Vaccination and methods against multiple sclerosis resulting from pathogenic responses by specific T cell populations
10/15/2002US6464973 Universal GM-CSF expressing bystander human K562 cell line
10/15/2002US6464851 Appropriate membranes used and the cartridge housing the membrane configured to include separate chambers for the isolated bacteria and viruses; gradiflow electrophoresis
10/10/2002WO2002079517A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
10/10/2002WO2002079478A2 Modification of organelle metabolism by a composition comprising unc-51-like kinases, roma1, or 2tm polypeptides and uses thereof for the preration of a medicament for the treatment disorders
10/10/2002WO2002079475A2 Streptococcus pyogenes antigens and corresponding dna fragments
10/10/2002WO2002079474A2 Human b7 polypeptides
10/10/2002WO2002079464A2 Viral vectors
10/10/2002WO2002079441A2 Secreted proteins
10/10/2002WO2002079429A2 Anti-muc-1 single chain antibodies for tumor targeting
10/10/2002WO2002079417A2 Methods of delivery of exogenous proteins to the cytosol and uses thereof
10/10/2002WO2002079404A2 Cytoskeleton-associated proteins
10/10/2002WO2002079396A2 Biological carriers for induction of immune responses
10/10/2002WO2002079257A1 Novel compound for treatment of allergy and asthma
10/10/2002WO2002079255A1 RECOMBINANT ANTIBODIES COEXPRESSED WITH GnTIII
10/10/2002WO2002079253A1 Wti modified peptide
10/10/2002WO2002079252A1 Isolated human transporter protein, nucleic acid molecules encoding human transporter protein, and uses thereof
10/10/2002WO2002079249A2 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
10/10/2002WO2002079248A2 Mammalian alpha-helical protein-53
10/10/2002WO2002079247A2 Intimins in the prevention or treatment of infections:ii
10/10/2002WO2002079244A2 Chlamydial protease-like activity factor responsible for degradation of host transcription factor
10/10/2002WO2002079243A2 Gonococcal proteins and nucleic acids
10/10/2002WO2002079242A2 Adp-ribosylating bacterial toxins
10/10/2002WO2002079241A2 Secreted streptococcus pneumoniae proteins
10/10/2002WO2002079240A2 Intimins for the prevention or treatment of infections: i
10/10/2002WO2002079238A2 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis
10/10/2002WO2002079237A2 Non-typeable haemophilus influenzae immunogenic polypeptides and use thereof
10/10/2002WO2002079231A2 Nucleic acids encoding isav polypeptides
10/10/2002WO2002078766A2 Combination therapy
10/10/2002WO2002078742A2 Methods and compositions for treatment of immune dysfunction disorders
10/10/2002WO2002078741A2 Methods and compositions for modulating the immune system of animals
10/10/2002WO2002078739A1 Drugs containing genetically modified antibody against ganglioside gd3
10/10/2002WO2002078738A1 Blood rheology improving agents
10/10/2002WO2002078736A2 Antiallergic pharmaceutical composition
10/10/2002WO2002078735A2 Leishmania vaccines
10/10/2002WO2002078734A1 Production of peptides in plants as n-terminal viral coat protein fusions
10/10/2002WO2002078733A1 Monocyte-specific particulate delivery vehicle
10/10/2002WO2002078731A1 Module of pd-1 interactions with its ligands
10/10/2002WO2002078717A2 Compositions and methods for reducing rna virus pathogenicity
10/10/2002WO2002078715A1 Method for induction of an antigen specific anti-inflammatory response
10/10/2002WO2002078698A2 Polarisation of dendritic cells (treatment of infections, cancer and autoimmune diseases) using histamine
10/10/2002WO2002078677A1 Colloidal suspension of nanoparticles based on an amphiphilic copolymer
10/10/2002WO2002078643A2 Immunomodulation and effect on cell processes relating to serotonin family receptors
10/10/2002WO2002078638A2 Morpholino imaging and therapy
10/10/2002WO2002078613A2 Immunoglobulin construct containing anti-mucin variable domain sequences for eliciting an anti-idiotype anti-tumor response
10/10/2002WO2002078609A2 Immunoglobulin construct containing tumor specific p53bp2 sequences for eliciting an anti-tumor response
10/10/2002WO2002078607A2 Mucin peptide with immunoenhancing properties
10/10/2002WO2002078603A2 Plasmodium falciparum erythrocyte binding protein baebl for use as a vaccine
10/10/2002WO2002078598A2 Peptides and antibodies to muc 1 proteins
10/10/2002WO2002078526A2 Cancer-testis antigens
10/10/2002WO2002078516A2 Compositions and methods for the therapy and diagnosis of cancer
10/10/2002WO2002070552A8 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF
10/10/2002WO2002034895A3 Novel aggrecanase molecules
10/10/2002WO2002034763A3 Mucin comprising vehicle for the transport of biologically-active agents
10/10/2002WO2002032450A3 Vaccines
10/10/2002WO2002030463A3 Reduced-viscosity concentrated protein formulations
10/10/2002WO2002028429A3 Modulation of allergic response
10/10/2002WO2002010343A3 Temperature-sensitive live vaccine for mycoplasma hyopneumoniae
10/10/2002WO2002004007A9 Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof
10/10/2002WO2002000694A3 Modified morbillivirus v proteins
10/10/2002WO2001078787A3 Lipopolysaccharide-conjugate vaccine for sepsis treatment
10/10/2002WO2001074382A9 Method of treatment using ligand-immunogen conjugates
10/10/2002WO2001064869A3 Tumor-related antigen
10/10/2002US20020147326 Fusion protein for use in the treatment of autoimmune diseases tissue grafting defect
10/10/2002US20020147325 Antibodies to receptor protein kinases
10/10/2002US20020147321 Chimeric gene formed of the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful for serologic diagnosis of canine leishmaniosis and protein obtained
10/10/2002US20020147314 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory bowel disease
10/10/2002US20020147311 Fusion protein for use in the treatment of tumors
10/10/2002US20020147310 Nucleotide sequences coding polypeptides for use in the treatment of inflammatory and autoimmune diseases
10/10/2002US20020147203 Tyrosine kinase inhibitors
10/10/2002US20020147143 Diagnosis, therapy; anticancer agents
10/10/2002US20020147130 Treatment of hiv
10/10/2002US20020146846 Novel method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment
10/10/2002US20020146828 Microparticles and methods for delivery of recombinant viral vaccines
10/10/2002US20020146820 Immunoreactive peptide CTL epitopes of human cytomegalovirus pp150
10/10/2002US20020146791 Corpuscles of stannius protein, stanniocalcin
10/10/2002US20020146776 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of bacterial infections
10/10/2002US20020146774 Smad2 phosphorylation and interaction with Smad4
10/10/2002US20020146772 Nucleotide equences coding enzymatic polypeptide for use in the treatment of blood disorders and thrombosis
10/10/2002US20020146770 RAS proteins
10/10/2002US20020146768 Apoliprotein for use in treatment of stroke, heart defects, reperfusion injuries, viral, nervous system, vision and blood disorders
10/10/2002US20020146762 Generating mutant polypeptides; obtain protein sample, incubate wih mutagen, recover and evaluate protein activity
10/10/2002US20020146759 Stress proteins and peptides and methods of use thereof
10/10/2002US20020146750 Mucin for use in the diagnosiss and treatment of cancer
10/10/2002US20020146749 Diagnosis and treatment of neuroectodermal tumors
10/10/2002US20020146738 Nucleotide sequences coding polypeptides for use in the treatment and prevention of infections
10/10/2002US20020146727 Compositions and methods for the therapy and diagnosis of breast cancer
1 ... 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 ... 1823